Artelo Biosciences Files 424B3 Prospectus

Ticker: ARTL · Form: 424B3 · Filed: Apr 16, 2026 · CIK: 0001621221

Sentiment: neutral

Topics: prospectus, offering, pharmaceuticals

Related Tickers: ARTL

TL;DR

ARTL filed a prospectus (424B3) on 4/16/26. Looks like they're raising money.

AI Summary

Artelo Biosciences, Inc. filed a 424B3 prospectus on April 16, 2026, detailing its offering. The company, located at 505 Lomas Santa Fe, Suite 160, Solana Beach, CA 92075, is involved in the Pharmaceutical Preparations industry. This filing is a standard prospectus supplement.

Why It Matters

This filing indicates Artelo Biosciences is actively engaging in capital raising activities, which could impact its financial structure and future operations.

Risk Assessment

Risk Level: medium — Prospectus filings (424B3) often precede or accompany significant corporate actions like stock offerings, which can introduce financial risk and dilution.

Key Numbers

Key Players & Entities

FAQ

What is the purpose of a 424B3 filing?

A 424B3 filing is a prospectus supplement used to provide additional information or update details about securities being offered or sold by a company, supplementing a previously filed registration statement.

When was this prospectus supplement filed?

This prospectus supplement was filed on April 16, 2026.

What is Artelo Biosciences, Inc.'s primary business?

Artelo Biosciences, Inc. operates in the Pharmaceutical Preparations industry, as indicated by its SIC code 2834.

Where is Artelo Biosciences, Inc. located?

The company's mailing and business address is 505 Lomas Santa Fe, Suite 160, Solana Beach, CA 92075.

What is the CIK number for Artelo Biosciences, Inc.?

The CIK number for Artelo Biosciences, Inc. is 0001621221.

Filing Details

This Form 424B3 (Form 424B3) was filed with the SEC on April 16, 2026 regarding ARTELO BIOSCIENCES, INC. (ARTL).

View full filing on EDGAR

View Full Filing

View this 424B3 filing on SEC EDGAR

View on Read The Filing